SARS-CoV-2 Spike S2 Protein, His Tag
CAT:
716-S2N-C52H5-100ug
Size:
100 µg
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


SARS-CoV-2 Spike S2 Protein, His Tag
Background:
It's been reported that SARS-CoV-2 can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.Description:
SARS-CoV-2 Spike S2, His Tag (S2N-C52H5) is expressed from human 293 cells (HEK293) . It contains AA Ser 686 - Pro 1213 (Accession # QHD43416.1) . Proline substitutions (F817P, A892P, A899P, A942P, K986P, V987P) are introduced to prevent the formation of aggregates in the course of protein production.Specifications:
This protein carries a polyhistidine tag at the C-terminus. The protein has a calculated MW of 60.0 kDa. The protein migrates as 65-115 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.Accession Number:
QHD43416.1Expression Region:
Ser 686 - Pro 1213Host:
HEK293Target:
Spike S2Conjugation:
UnconjugatedTag:
C-10xHisSource:
SARS-CoV-2Stability:
● -20°C to -70°C for 12 months in lyophilized state; ● -70°C for 3 months under sterile conditions after reconstitution. For long term storage, the product should be stored at lyophilized state at -20°C or lower.Endotoxin:
1.0 EU per μgPurity:
90%Bioactivity:
Immobilized SARS-CoV-2 Spike S2, His Tag (Cat. No. S2N-C52H5) at 1 μg/mL (100 μL/well) can bind SARS-CoV-2 Spike S2 Antibody, Human IgG1 with a linear range of 0.4-3 ng/mL (QC tested).Format:
PowderBuffer:
PBS, pH7.4Additives:
TrehaloseMolecular Weight:
60.0 kDaShipping Conditions:
RTStorage Conditions:
-20°CPackage Size:
100ug*1Species:
SARS-CoV-2